Apieron
Apieron Inc. was a private, venture-backed medical device company headquartered in Menlo Park, California, formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) as an aid in the management of asthma. Its patented biosensor platform enabled highly sensitive detection of selected analytes, and its Insight eNO System received U.S. Food and Drug Administration clearance and launched in the United States in 2008. Following that launch Aerocrine filed patent-infringement complaints against Apieron and Apieron counterclaimed; citing the legal setbacks and a lack of financing, Apieron filed a Chapter 7 bankruptcy petition in the U.S. Bankruptcy Court for the Northern District of California on 30 March 2010. At a court auction on 12 May 2010 Aerocrine acquired all of Apieron's business assets, including its patent and trademark portfolio, ending the litigation; the Insight product was discontinued and not returned to supply. Apieron was a clinical-hardware company and never published a public API, developer portal, SDK, or machine-readable interface. This profile is retained as a historical record of the Canaan Partners portfolio and is not an active API provider.
Apieron is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Respiratory, and Asthma.
scored 2026-11-06 · rubric v0.27.0 · Show this score on your site →
Kin Score
Kin Score
How this is scored →scored 2026-11-06 · rubric v0.27.0
<a href="https://apis.io/providers/apieron/"><img src="https://apis.io/badge/apieron/card.svg" alt="Apieron on APIs.io — Kin Score by API Evangelist"></a>Other styles, a README pill and a shields.io endpoint are on the badge page.
- Machine-Readable Contract +18 pts — api_specs includes an OpenAPI document
- MCP Server +12 pts — deployment.mode + probe verdict on the mcp/ manifest, not the pointer; an unprobed slug falls back to authorship
- Agentic Access Contract +10 pts — agentic_access artifact present (x-agentic-access), graded by author
- Machine-Readable Auth +10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
- Idempotency +9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
- Stable Error Semantics +8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
- Contract Quality scores 0.0 — up to +25.0 composite points
- Developer Ergonomics scores 0.0 — up to +20.0 composite points
- Access Clarity scores 0.0 — up to +20.0 composite points
Resources
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
aid: apieron
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-11-06'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/apieron.png
name: Apieron
description: Apieron Inc. was a private, venture-backed medical device company headquartered in Menlo Park, California, formed
in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) as an aid
in the management of asthma. Its patented biosensor platform enabled highly sensitive detection of selected analytes, and
its Insight eNO System received U.S. Food and Drug Administration clearance and launched in the United States in 2008. Following
that launch Aerocrine filed patent-infringement complaints against Apieron and Apieron counterclaimed; citing the legal
setbacks and a lack of financing, Apieron filed a Chapter 7 bankruptcy petition in the U.S. Bankruptcy Court for the Northern
District of California on 30 March 2010. At a court auction on 12 May 2010 Aerocrine acquired all of Apieron's business
assets, including its patent and trademark portfolio, ending the litigation; the Insight product was discontinued and not
returned to supply. Apieron was a clinical-hardware company and never published a public API, developer portal, SDK, or
machine-readable interface. This profile is retained as a historical record of the Canaan Partners portfolio and is not
an active API provider.
url: https://raw.githubusercontent.com/api-evangelist/apieron/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: historical
x-tier-reason: defunct-2010-no-api-surface
x-status: defunct
x-status-detail: Filed Chapter 7 bankruptcy 30 March 2010 (N.D. Cal.); all business assets, patents, and trademarks acquired
by Aerocrine AB at a bankruptcy auction on 12 May 2010. The Insight eNO System was discontinued and not returned to supply.
x-acquired-by: Aerocrine AB
x-acquired-year: 2010
x-acquisition-type: bankruptcy-asset-sale
x-acquisition-source: https://www.globenewswire.com/news-release/2010/04/07/230395/0/en/Aerocrine-provides-update-on-its-legal-action-against-Apieron.html
x-acquirer-successor: Aerocrine AB was itself acquired by Circassia Pharmaceuticals plc in June 2015; Circassia Group plc
rebranded to NIOX Group plc in 2022. aerocrine.com no longer resolves (probed 2026-07-19); the successor surface is https://www.niox.com/.
x-founded-year: 2001
x-headquarters: Menlo Park, California, United States
x-sector: Medical Devices
x-total-funding: $62.6 million
x-other-investors:
- Draper Fisher Jurvetson
- ONSET Ventures
- Technology Alliance Ventures
x-domain-status:
domain: apieron.com
probed: '2026-07-19'
result: parked-for-sale
note: 'apieron.com resolves and returns HTTP 200, but 307-redirects to a GoDaddy aftermarket for-sale lander. Every probed
path returns the identical lander body: /.well-known/security.txt, /.well-known/openid-configuration, /.well-known/oauth-authorization-server,
/.well-known/api-catalog and /.well-known/ai-plugin.json all byte-match the response for a randomly generated nonexistent
path (md5 e89f75f918dbdcee28604d4e09dd71d7), so those 200 status codes are wildcard false positives and no well-known
artifacts were saved. A /llms.txt is served but describes the GoDaddy domain listing rather than the company, and was
likewise not saved.'
x-enrichment:
date: '2026-07-19'
status: nochange
artifacts_added: 0
pass: local-v1
rationale: Searched and probed successfully. Entity is defunct (Chapter 7 in 2010; assets absorbed by Aerocrine) and published
no API, developer portal, SDK, or specification during its operating life. Its former domain is now a GoDaddy for-sale
parking page whose wildcard 200s were rejected as false positives. No artifacts were generated; fabricating any would
be unfaithful.
x-disambiguation:
- name: Apeiron
url: https://apeiron.io/
relationship: unrelated-name-collision
note: 'Apeiron (note the different spelling: "Apeiron", not "Apieron") is a present-day communications platform publishing
voice/SIP trunking, SMS/MMS, phone number, E911 and cellular MVNE APIs with Postman collections at https://apeiron.io/docs.
It is a separate company and is not the Canaan Partners portfolio company profiled here; its API surface must not be attributed
to Apieron Inc.'
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-09-15'
tags:
- Company
- Medical Devices
- Healthcare
- Respiratory
- Asthma
- Diagnostics
- Biosensors
- Acquired
- Historical
- Defunct
apis: []
common:
- type: Acquirer
name: Aerocrine AB (now NIOX Group plc)
url: https://www.niox.com/
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.
MCP server
One button, every client — Claude, Cursor, VS Code and the rest.
https://apis.io/mcp
Tools for providers
9 MCP tools reach this
find_providersBrowse and filter every provider in the catalog.get_provider_artifactsEvery artifact this provider publishes, grouped by type.get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.get_provider_toolsEvery MCP tool they ship, with the operation each wraps.get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.get_provider_ratingPRO — composite, band, trend and facet scores.apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.resolveTurn a domain, URL or GitHub org into the provider it belongs to.find_cohortsEvery scored population of providers in the catalog.
Call it yourself
curl for this page
curl "https://apis.io/api/v1/providers/apieron"
curl "https://apis.io/api/v1/providers?limit=25"
curl "https://apis.io/api/v1/providers/apieron/operations?limit=25"
curl "https://apis.io/api/v1/providers/apieron/evidence"
Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.
A second provider on the same verified email joins the account you already have.